1Van Der Meer IM, De Maat MP, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study [J]. Stroke,2002,33 (12) :2 750 - 2 755.
5Silvestri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reaetive protein and interleukin-6 prediet outeome in elderly patients with stroke[J]. J Am Geriatr Soc,2004,52(9) :1 586- 1 587.
7Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atheroselerosis in hypertensive subjects [ J ]. Stroke ,2004,35 (7) : 1 625 - 1 630.
8Yasojima K, Schwab C, McGeer EG, et al. Generation of C-reactive protein and complement components in atherosclerotic plaques[J]. Am J Pathol,2001,158 ( 3 ) : 1 039 -1 051.
3Studahl M,Rosengren L,Gumther G,et al.Difference in pathogeneis between herpes simplex virus type 1 encephalitis and tick-brone encephaligis demonstrated by means of cerebrospinal fluid markers of glial and neuronal destruction[J].J Neurol,2000,247(8):636-642.
4Patrick L,Uzick M.Cardiovascular disease:C-reactive protein and inflammatory disease paradigm:HMG-CoA reductase inhibitors,alpha-tocopherol,red yeast rice,and olive oil polyphenols.A review of the literature[J].Altern Med Rev,2001,6(3):248-271.
5Winbeck K,Poppert H,Etgen T,et al.Prognostic relecance of early serial C-reactive protein measurements after first ischemic stroke[J].Stoke,2002,33(10):2459-2464.
6Blake GJ,Ridker PM.Novel clinical markers of vascular wall inflammation[J].Circ Res,2001,89(9):763-771.
7Bickel C,Rupprecht HJ,Blankenberg S,et al.Relation of markers of inflammation(C-reactive protein,fibrinogen,von willebrand factor,and leukocyte count)and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease[J].Am J Cardiol,2002,89(8):901-908.
8Ridker PM,Cushman M,Stampfer MJ,et al.Inflammation aspirin and the risk of cardiovascular disease in apparently healthy men[J].N Engl J Med,1996,336(14):973-979.
9Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarctiona report of american collage of earidogy/ameriean heart association task force on practice guidelines (Committe on the management of patients with unstadle angina)[J]. J Am Coll Cardiol, 2000, 36(3): 970-1 062.
10Pasceri V, Cheng JS, WiUerson JT, et al. Modulation of C-reactive protein-mediated monocyte chemoattractant prorein-1 induction in human endothelial cells by anti-atherosclerosis drugs [J]. Circulation, 2001, 103 (21): 2 531-2 534.
